The Company is under no obligation to provide any updates to any information contained in this release. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The words вЂњbelieve,вЂќ вЂњdemonstrate,вЂќ вЂњintend,вЂќ вЂњexpect,вЂќ вЂњestimate,вЂќ вЂњwill,вЂќ вЂњcontinue,вЂќ вЂњanticipate,вЂќ вЂњlikely,вЂќ вЂњseek,вЂќ and similar expressions identify forward-looking statements.

Such factors include, but are not limited to, the CompanyвЂ™s ability to achieve business and strategic objectives, increase sales and acceptance of products, adoption by CMS of a new payment model, and that such model will prove beneficial to the Company, which is not assured, implement expansion plans, the risks of uncertainty of patent protection, the impact of supply and manufacturing constraints or difficulties, uncertainty of future sales levels, protection of patents and other proprietary rights, the impact of supply and manufacturing constraints or difficulties, product market acceptance, possible technological obsolescence of products, increased competition, ability to successfully defend itself in litigation matters, government regulation, changes in Medicare or other reimbursement policies, risks relating to our existing and future debt obligations, competitive factors, the effects of a decline in the economy or markets served by the Company the effects of a global pandemic, and other risks detailed in the CompanyвЂ™s filings with the Securities and Exchange Commission. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. For example, when the Company discusses the potential of ProFound AIВ® Risk, the benefits of the CompanyвЂ™s products, the Enterprise sales cycle, trends driving positive shifts, and clinical plans and updates, it is using forward-looking statements. For more information, visit 'Safe Harbor' Statement under the Private Securities Litigation Reform Act of 1995Д¬ertain statements contained in this News Release constitute вЂњforward-looking statementsвЂќ within the meaning of the Private Securities Litigation Reform Act of 1995. Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. Management will be available to host virtual one-on-one meetings with investors who are registered to attend the conference.

(NASDAQ: ICAD),В a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will participate in the 12 th Annual Craig-Hallum Alpha Select Conference on Tuesday, November 16, 2021, starting at 9:00 AM ET.

Icad stocktwits